PM360: Cambrian is Using a New Drug Discovery Model to Solve the Science of Aging

15

 min read

26

Apr

21

Cambrian Biopharma is one of the newly emerging distributed drug discovery companies that applies a new twist to investing in interesting science. PM360 spoke with co-founder James Peyer about this new model, why he decided to focus on the biology of aging, and more.

>